Zomedica shareholders reject advisory vote on executive compensation at 2025 annual meeting

Zomedica Corp.

Advisory vote on NEO compensation failed: 56.7M for, 82.4M against, 32.3M abstain.
All eight director nominees elected; Larry Heaton received lowest support (85.3M for, 86.1M against).
Ratification of Grant Thornton LLP as auditor for 2025 approved with 310.6M votes for.
Meeting held June 10, 2025; results disclosed in Form 8-K filed June 11, 2025.

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.